myRAteam

Yes, Remicade (infliximab) is a biologic DMARD used to treat moderate to severe rheumatoid arthritis, often in combination with methotrexate. It works by targeting TNF-α, reducing inflammation. Infusions are given every 4 or 8 weeks after initial doses. Common side effects include infections, infusion reactions, headache Show Full Answer

Yes, Remicade (infliximab) is a biologic DMARD used to treat moderate to severe rheumatoid arthritis, often in combination with methotrexate. It works by targeting TNF-α, reducing inflammation. Infusions are given every 4 or 8 weeks after initial doses. Common side effects include infections, infusion reactions, headache, and abdominal pain. Serious risks include severe infections, lymphoma, and liver damage. For more, visit: url: https://www.myrateam.com/treatments/remicade.

 AI-generated responses are not a substitute for medical advice. These services are not intended to diagnose, treat, or cure any condition or disease. Always ask your doctor about specific health concerns.

Remicade (Infliximab) for Rheumatoid Arthritis | myRAteam

Infusion Therapy for Rheumatoid Arthritis: Your Guide | myRAteam